These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 9678977)
1. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease. Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977 [No Abstract] [Full Text] [Related]
2. Tacrine: a second look. An outdated drug to be discarded. Prescrire Int; 1999 Feb; 8(39):16-8. PubMed ID: 10557569 [TBL] [Abstract][Full Text] [Related]
3. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial]. Wallin A Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526 [No Abstract] [Full Text] [Related]
5. [Balance sheet of tolerance-efficacy on the use of tacrine in 100 cases of Alzheimer's disease]. Estadieu MC; Machou C; Berthezène P; Pastor MJ; Angelini B; Bohor M; Bongrand MC; Timon-David P; Gastaut JL; Allain H; Michel BF Therapie; 1998; 53(1):67-76. PubMed ID: 9773102 [TBL] [Abstract][Full Text] [Related]
6. Mixed-model analysis of incomplete longitudinal data from a high-dose trial of tacrine (Cognex) in Alzheimer's patients. Smith F J Biopharm Stat; 1996 Mar; 6(1):59-67. PubMed ID: 8838779 [TBL] [Abstract][Full Text] [Related]
7. [Tacrine]. Dávila C; Viteri C; de Castro P Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715 [TBL] [Abstract][Full Text] [Related]
8. Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic. Lyketsos CG; Corazzini K; Steele CD; Kraus MF J Neuropsychiatry Clin Neurosci; 1996; 8(1):67-73. PubMed ID: 8845704 [TBL] [Abstract][Full Text] [Related]
9. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease]. García-Díaz JD; Fraguas C; Garcimartín C Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247 [No Abstract] [Full Text] [Related]
10. Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study. Gutzmann H; Kühl KP; Hadler D; Rapp MA Pharmacopsychiatry; 2002 Jan; 35(1):12-8. PubMed ID: 11819153 [TBL] [Abstract][Full Text] [Related]
11. Tolerance to tacrine, arterial hypotension and leuko-araiosis in Alzheimer's disease. Lebert F; Mouly C; Pasquier F Age Ageing; 1998 Sep; 27(5):654. PubMed ID: 12675108 [No Abstract] [Full Text] [Related]
12. Cognition-enhancing drugs in dementia: a guide to the near future. van Reekum R; Black SE; Conn D; Clarke D Can J Psychiatry; 1997 Jun; 42 Suppl 1():35S-50S. PubMed ID: 9220128 [TBL] [Abstract][Full Text] [Related]